SYNSIGHT

We are now integrated in iktos company! Please follow our drug discovery journey there. 🚀

Pioneering AI in Drug Discovery! 🔬 At SYNSIGHT, our commitment to revolutionizing drug discovery through artificial intelligence takes another leap forward. We're thrilled to highlight a pivotal study from Nature Scientific Reports, showcasing the power of AI in High Content Screening (HCS) image analysis. Researchers led by Auguste Genovesio demonstrate how transfer learning from an AI vision algorithm, can be applied to analyze vast amounts of cell imaging data efficiently in HCS without the need for any specialized training. This approach facilitates quicker, more flexible analyses, crucial in advancing RNA-targeted drug discovery efforts. This study exemplifies the synergy of AI and HCS, underscoring technologies that are at the heart of Synsight's pioneering approach to develop novel RNA-targeting drugs. Dive into this insightful read: https://lnkd.in/etEEHUU6

Last week, SYNSIGHT was part of Genopole delegation in Dubaï and Abu Dhabi 🤝

live cell assays & AI Drug discovery this article is a must read about live cell assays and AI drug discovery! the best association in my opinion between in silico and real life data: to validate hypothesis but also a huge way to create meaningful robust dataset to train AI models. Feel free to reach SYNSIGHT team to build such a collaboration, using our patented cell assay for PPI and P-RNA interactions. https://lnkd.in/ekQkT4j9

🔬 Exciting times at SYNSIGHT! 🔍 Introducing the brilliant work of our PhD candidate, Ethan Cohen, who recently impressed us at IBENS Transversal Topics day: ML and Biology. 💻 ⚗ Ethan is at the forefront of our mission to revolutionize drug discovery using the power of AI and cell painting. Incorporating cutting-edge deep learning techniques with the intricacies of biology, we're paving the way for more efficient and effective drug discovery processes. 🚀 At SYNSIGHT, we're dedicated to merging science and technology to advance drug discovery, and Ethan Cohen's groundbreaking research embodies that commitment. Stay tuned for more updates as we continue to drive innovation in biotech/techbio! #biotechinnovation #aidrugdiscovery #drugdiscovery #techbio

Ever thought about the challenges of targeting RNA in drug discovery? 🧬 Discover our breakthrough with our latest application note, showcasing our patented RNA-Protein targeting technology: https://buff.ly/3vvtHS6 Our technology represents a paradigm shift in cellular screening, grounded in the mechanism of action. We complement this with phenotype-based techniques, also at the cellular level. This comprehensive approach, offering a full view of the molecule and its activity, drives drug discovery efficiently. Supported by our #techbio team and local actors like Genopole and Bpifrance, we're turning the complex world of RNA targeting into a realm of immense possibilities. Join us in this pioneering journey of pharmaceutical innovation!

Eager to transform the landscape of drug discovery? Envision a world where breakthrough innovation tames the most challenging targets: protein-protein and protein-RNA interactions! Our latest application note explains how we use innovative technologies and techniques to create effective and safe drugs. We have developed a streamlined process that accelerates drug discovery and optimization by leveraging AI drug design and our patented cell-based assay originated from INSERM, unlocking protein-protein and protein-RNA interactions. If you are interested in learning more, see our application note now on our website, and/or feel free to contact us! https://buff.ly/41tNRaX #rnatherapeutics #drugdiscovery #RNAProteinInteractions Genopole Bpifrance Région Ile de France Medicen Paris Region Systematic Paris-Region

Eager to transform the landscape of drug discovery? Envision a world where breakthrough innovation tames the most challenging targets: protein-protein and protein-RNA interactions! Our latest application note explains how we use innovative technologies and techniques to create effective and safe drugs. We have developed a streamlined process that accelerates drug discovery and optimization by leveraging AI drug design and our patented cell-based assay originated from INSERM, unlocking protein-protein and protein-RNA interactions. If you are interested in learning more, see our application note now on our website, and/or feel free to contact us! https://buff.ly/41tNRaX #rnatherapeutics #drugdiscovery #RNAProteinInteractions Genopole Bpifrance Région Ile de France Medicen Paris Region Systematic Paris-Region

Eager to transform the landscape of drug discovery? Envision a world where breakthrough innovation tames the most challenging targets: protein-protein and protein-RNA interactions! Our latest application note explains how we use innovative technologies and techniques to create effective and safe drugs. We have developed a streamlined process that accelerates drug discovery and optimization by leveraging AI drug design and our patented cell-based assay originated from INSERM, unlocking protein-protein and protein-RNA interactions. If you are interested in learning more, see our application note now on our website, and/or feel free to contact us! https://buff.ly/41tNRaX #rnatherapeutics #drugdiscovery #RNAProteinInteractions Genopole Bpifrance Région Ile de France Medicen Paris Region Systematic Paris-Region